Home  >  Products  >  RDH12 (retinol dehydrogenase 12 (all-trans/9-cis/11-cis)) Blocking Peptide (the middle region of protein) (100ug)
RDH12 (retinol dehydrogenase 12 (all-trans/9-cis/11-cis)) Blocking Peptide (the middle region of protein) (100ug)

RDH12 (retinol dehydrogenase 12 (all-trans/9-cis/11-cis)) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RDH12 antibody (Catalogue #: ARP52973_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP52973
Size: 100 ug
Weight: 35kDa
Gene: 145226
Format: Lyophilized powder
Target: RDH12 is an NADPH-dependent retinal reductase whose highest activity is toward 9-cis and all-trans-retinol. RDH12 also plays a role in the metabolism of short-chain aldehydes but does not exhibit steroid dehydrogenase activity. Defects in this gene are a cause of Leber congenital amaurosis type 3 (LCA3). The protein encoded by this gene is an NADPH-dependent retinal reductase whose highest activity is toward 9-cis and all-trans-retinol. The encoded enzyme also plays a role in the metabolism of short-chain aldehydes but does not exhibit steroid dehydrogenase activity. Defects in this gene are a cause of Leber congenital amaurosis type 3 (LCA3).
Alternative names: FLJ30273; LCA3
See Full Product Listings >